Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03267186
Title Ibrutinib in Preventing Acute Leukemia in Patients After Reduced-Intensity Conditioning and Stem Cell Transplant
Recruitment Completed
Gender
Phase Phase II
Variant Requirements No
Sponsors Andrew Rezvani
Indications
Therapies
Age Groups:
Covered Countries USA


No variant requirements are available.